The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. by Shipley, J, Clark, J, Crew, A, Birdsall, S, Rocques, P, Gill, S, Chelly, J, Monaco, A, Abe, S, Gusterson, B

Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) by Chisholm, J, Mandeville, H, Adams, M, Minard-Collin, V, Rogers, T, Kelsey, A, Shipley, J, van Rijn, RR, de Vries, I, van Ewijk, R, de Keizer, B, Gatz, SA, Casanova, M, Hjalgrim, LL, Firth, C, Wheatley, K, Kearns, P, Liu, W, Kirkham, A, Rees, H, Bisogno, G, Wasti, A, Wakeling, S, Heenen, D

Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response by Zhang, P, Kitchen-Smith, I, Xiong, L, Stracquadanio, G, Brown, K, Richter, PH, Wallace, MD, Bond, E, Sahgal, N, Moore, S, Nornes, S, De Val, S, Surakhy, M, Sims, D, Wang, X, Bell, DA, Zeron-Medina, J, Jiang, Y, Ryan, AJ, Selfe, JL, Shipley, J, Kar, S, Pharoah, PDP, Loveday, C, Jansen, R, Grochola, LF, Palles, C, Protheroe, A, Millar, V, Ebner, DV, Pagadala, M, Blagden, SP, Maughan, TS, Domingo, E, Tomlinson, I, Turnbull, C, Carter, H, Bond, GL

8-substituted pyrido[3,4-d]pyrimidin-4(3H)-one derivatives as potent, cell permeable, KDM4 (JMJD2) and KDM5 (JARID1) histone lysine demethylase inhibitors by Bavetsias, V, Lanigan, R, Ruda, G, Atrash, B, McLaughlin, M, Tumber, A, Mok, N, Le Bihan, Y, Dempster, S, Boxall, K, Jeganathan, F, Hatch, S, Savitsky, P, Velupillai, S, Krojer, T, England, K, Sejberg, J, Thai, C, Donovan, A, Pal, A, Scozzafava, G, Bennett, J, Kawamura, A, Johansson, C, Szykowska, A, Gileadi, C, Burgess-Brown, N, von Delft, F, Oppermann, U, Walters, Z, Shipley, J, Raynaud, F, Westaway, S, Prinjha, R, Fedorov, O, Burke, R, Schofield, C, Westwood, I, Bountra, C, Müller, S, van Montfort, R, Brennan, P, Blagg, J